Select a community
All Communities
Home > Community Treatment Reports > Oxazepam Treatment Report
What is Oxazepam?

Oxazepam is a benzodiazepine used to treat anxiety. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 11 2
Anxiety 4 2
SLEEP. SEIZURES 1 0
unable to fall asleep 1 0
anxiety and irritability 1 1
Emotional lability 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 20%
Moderate
1 20%
Mild
0 0%
None
3 60%

Most commonly reported side effects

Lightheadedness
2 40%
Nausea
1 20%
extremely drowzy
1 20%
  • Mild
  • Moderate
  • Severe

Dosages

  15mg as needed 30mg as needed daily 10 mg daily 15 mg daily 20 mg daily 30 mg daily 45 mg daily 60 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 5 Number of Patients: 5 4 Number of Patients: 4 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Oxazepam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
2 33% Did not seem to work: 33%
Side effects too severe
2 33% Side effects too severe: 33%

See all 4 patients who’ve stopped taking Oxazepam

Currently Taking Oxazepam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
2
5

Stopped Taking Oxazepam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
0
2
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
3 60%
Usually
1 20%
Sometimes
1 20%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
5 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 20%
< $25
2 40%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.